Status:
UNKNOWN
The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH)
Lead Sponsor:
Samsung Medical Center
Conditions:
Gynecologic Operations
Anti-Mullerian Hormone
Eligibility:
FEMALE
20-49 years
Brief Summary
Besides the removal of lesions, the purpose of surgeries has been extended to the improvement of quality of life after procedures. Minimally invasive surgeries enabled women to experience less pain, l...
Detailed Description
Premenopausal women were enrolled and were allocated into two groups; operation and control group. Operations were performed for benign ovarian tumors, leiomyoma or adenomyosis. All eligible women wer...
Eligibility Criteria
Inclusion
- For both operation and control groups, women were eligible for inclusion if they had regular menstrual cycles and no history of pelvic surgery.
Exclusion
- No endocrine disorders (e.g. PCOS).
- Received any kind of medication that could affect the results within the preceding 6 months.
- Any woman who had a suspected pathologic lesion in the ovary or menopausal symptoms.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00928044
Start Date
January 1 2008
End Date
July 1 2009
Last Update
June 25 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.